Oxaliplatin: all 947 studies that test it
Page 7 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- SOX as Salvage Treatment in Nasopharyngeal CarcinomaTerminatedNCT01403259Phase 2
- Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursCompletedNCT01397019Phase 2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast CancerCompletedNCT01387373Phase 2
- Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck CancerTerminatedNCT01370876Phase 2
- Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma PatientsCompletedNCT01366118Not applicable
- A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerCompletedNCT01364493Phase 2
- S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaCompletedNCT01364376Not applicable
- Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid TumorsCompletedNCT01362374Phase 1
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01351597Phase 2
- Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric AdenocarcinomaTerminatedNCT01351038Phase 2
- Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy FailureCompletedNCT01348412Phase 2
- Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric CancerStatus unknownNCT01331928Phase 2
- Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic CancerTerminatedNCT01314027Phase 3
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerStatus unknownNCT01308086Phase 3
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable CancerCompletedNCT01295086Not applicable
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTCCompletedNCT01267344Phase 2
- Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by SurgeryCompletedNCT01263171Phase 2
- Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based TreatmentCompletedNCT01262482Phase 2
- A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver MetastasesCompletedNCT01260415Phase 2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaCompletedNCT01247337Phase 2
- Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNCT01245582Phase 3
- Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01234051Phase 2
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant SettingStatus unknownNCT01227239Phase 1/2
- Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedNCT01225744Phase 2
- Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / DocetaxelCompletedNCT01222312Phase 2
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Cetuximab + Gemox in Biliary Tract CancerCompletedNCT01216345Phase 2
- Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal CancerStatus unknownNCT01211210Phase 2/3
- Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and IIIStatus unknownNCT01196260Phase 2/3
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerCompletedNCT01163396Phase 2
- Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric CancerStatus unknownNCT01160419Phase 2
- FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)CompletedNCT01138904Phase 2
- Salvage mFOLFOX in BTC After Failure of GemcitabineCompletedNCT01127555Phase 2
- Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
- Randomized Study With Oxaliplatin in 2nd Line Pancreatic CancerCompletedNCT01121848Phase 3
- Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in ChinaCompletedNCT01110941Phase 1/2
- Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RTTerminatedNCT01106066Phase 1/2
- A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer PatientsStatus unknownNCT01100801Phase 2
- Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer TherapyStatus unknownNCT01092481Phase 3
- Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerStatus unknownNCT01090505Phase 2
- Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)CompletedNCT01068392Phase 2
- Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
- A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerStatus unknownNCT01064999Phase 2/3
- A Study of Locally Advanced Pancreatic CancerStatus unknownNCT01063192Phase 2
- Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal CancerActive, not recruitingNCT01061515Phase 1
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Isolated Liver Perfusion With OxaliplatinCompletedNCT01042691Phase 1
- Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum TherapyCompletedNCT01039155Phase 1
- Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
- OPTIMOX1 in Chinese mCRC PatientsStatus unknownNCT01023633Phase 4
- Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
- Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.Status unknownNCT01019863Phase 2
- Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal CancerCompletedNCT01013805Phase 2
- Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)Status unknownNCT00997685Phase 2
- Colorectal Cancer RECHALLENGEWithdrawnNCT00988897Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
- Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and CisplatinCompletedNCT00976768Phase 2
- Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric CancerStatus unknownNCT00961077Phase 2
- Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent LymphomaTerminatedNCT00954005Phase 1/2
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsCompletedNCT00952003Phase 2
- Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal CancerTerminatedNCT00950820Phase 2
- Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver CancerCompletedNCT00941967Phase 2
- Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung CancerStatus unknownNCT00923637Phase 2
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer RectumCompletedNCT00909987Phase 2
- Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinStatus unknownNCT00884767Phase 2
- Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00873275Phase 1
- Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaCompletedNCT00861783Phase 1
- Safety Study of ON 01910.Na in Combination With Irinotecan or OxaliplatinCompletedNCT00861328Phase 1
- Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionCompletedNCT00849615Phase 2
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG CancerTerminatedNCT00824785Phase 3
- Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal AdenocarcinomaCompletedNCT00816543Phase 2
- A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without CetuximabStatus unknownNCT00795301Phase 2
- Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerTerminatedNCT00782041Phase 2
- Combined Biological Treatment and Chemotherapy for Patients With Inoperable CholangiocarcinomaCompletedNCT00779454Phase 2
- Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT00769405Phase 3
- Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00766155Phase 3
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal CancerCompletedNCT00749450Phase 3
- Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic CarcinomaCompletedNCT00744640Phase 1/2
- FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal CarcinomaWithdrawnNCT00735241Phase 2/3
- Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusCompletedNCT00733616Phase 2
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- Gemcitabine/Oxaliplatin and Photodynamic Therapy in CholangiocarcinomaWithdrawnNCT00713687Phase 2
- Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas AdenocarcinomaCompletedNCT00707278Phase 1
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal CancerCompletedNCT00695201Phase 1
- Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic CancerStatus unknownNCT00690300Phase 2